Kalesh, Karunakaran
Lukauskas, Saulius
Borg, Aaron J.
Snijders, Ambrosius P. http://orcid.org/0000-0002-5416-8592
Ayyappan, Vinay
Leung, Anthony K. L. http://orcid.org/0000-0001-5569-4036
Haskard, Dorian O.
DiMaggio, Peter A. http://orcid.org/0000-0003-1996-0813
Funding for this research was provided by:
GlaxoSmithKline
RCUK | Biotechnology and Biological Sciences Research Council (1377205)
Cancer Research UK (FC001999, FC001999)
RCUK | Medical Research Council (FC001999, FC001999)
Wellcome Trust (FC001999, FC001999)
Article History
Received: 14 November 2018
Accepted: 11 April 2019
First Online: 30 April 2019
Competing Interests
: K.K., S.L. and P.A.D. have a patent application pending for the utilisation of the dual metabolic labelling using 2YnAd and 6YnAd for identification of intracellular ADP-ribosylation (Application number: 1810697.1). A.J.B., A.P.S., D.O.H., V.A. and A.K.L.L. declare no competing interests.